Dr. Aimee Kao looks at recent news in Alzheimer's Disease therapeutics including drugs in development and the potential of stem cells and genome editing. Series: "Mini Medical School for the Public" [Show ID: 35238]

Alzheimer's Disease (Video)

Staying Sharp: Current and Future Approaches to Brain Health and Alzheimer’s Therapeutics

David M. Holtzman, MD of the Washington University School of Medicine discusses the mechanisms underlying neurodegeneration and how microglia and specific microglial genes such as TREM2 influence neurodegeneration in the setting of Aβ and tau pathology. Learn how this line of study may lead to new therapeutics and diagnostic testing for Alzheimer's disease. Series: "Brain Channel" [Professional Medical Education] [Show ID: 35262]

APOE TREM and Microglia in the Pathogenesis of Tau-mediated Neurodegeneration with David Holtzman MD - Shiley Endowed Lecture

Worldwide 50 million people live with dementia. By 2040 over 70% of them will be living in the developing world. Dr. Shamiel McFarlane explores the social and economic cost of dementia around the world. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34779]

The Burden of Alzheimer’s Disease and Related Diseases in Vulnerable Populations

There are modifiable behaviors that may reduce the risk factor of Alzheimer's: vascular disease, sedentary lifestyle, depression/stress, diet factors and alcohol. Kaitlin Casaletto talks about the benefits of an active lifestyle and proper nutrition. Then Dr. Joanna Hellmuth looks at how to decode direct-to-consumer interventions - dietary supplements - and the rise of pseudo-medicine for dementia. She explains that supplements may or may not be safe and that manufacturers can make broad claims without supporting evidence. Series: "Mini Medical School for the Public" [Show ID: 35136]

Brain Health Promotion Strategies: Separating Reality-Based Hope From Hopeless Pseudo-Medicine

Dr. Julio Rojas-Martinez discusses the pharmacological treatment of Alzheimer’s disease now and what is in development. Current approaches pursue early intervention in the dementia phase. Novel emerging strategies will likely accompany anti-amyloid and anti-tau approaches in the future. Then Sarah Dulaney, RN, describe dementia education, support, and non-pharmacological treatment strategies. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34777]

Treatment and Management of Patients with Neurodegenerative Disease: Current State of Science

Alzheimer’s disease is the most common but not the only cause of dementia throughout the lifespan. Dr.Salvatore Spina discusses frontotemporal dementias and how they differ. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34776]

Looking Beyond Alzheimer’s Disease: An Overview of Other Major Forms of Neurodegenerative Disease

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Diagnosing Alzheimer’s Disease: From Genetics Neuropathology to Common and Rare Clinical Manifestations of the Disease

Neurologist Dr. Serggio Lanata explores the neurodegenerative disease of the brain, what they have in common and how they differ. alzheimer's is the most common neurodegenerative disease but there are several others including Parkinson's, Huntington Disease and others. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34774]

A Brief Overview of the Neurodegenerative Diseases of the Brain

More than 5 million Americans are currently diagnosed with Alzheimer’s disease, and that number is expected to triple by 2050, without prevention or cure. By 2060, the number of Latinos in the United States living with Alzheimer’s disease is projected to increase 832 percent — from 379,000 in 2012, to more than 3.5 million. Find out what UC San Diego is doing to both serve this community and catalyze the research careers of investigators from underrepresented groups. Series: "Brain Channel" [Health and Medicine] [Show ID: 34417]

Young Latino Scientists Working on Alzheimer's

Alex Figueroa and Dr. Jose Soria-Lopez discuss clinical symptoms of Alzheimer's Disease and the need to include the Latino community in clinical research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 34416]

Investigation About Alzheimer's Disease in the Latino Community (English Subtitles)

Este es el primer episodio en español de la Universidad de San Diego California sobre la investigación de la Enfermedad de Alzheimer Demencia en la comunidad latina. En este episodio Alex Figueroa y el Dr. Jose Soria-Lopez conversan sobre los síntomas clínicos y la necesidad de incluir la comunidad latina en investigaciones clínicas sobre esta enfermedad. Se mencionan maneras de combatir la enfermedad y recursos sociales que están disponibles para personas con esta enfermedad y familiares. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34205]

Investigación sobre la Enfermedad de Alzheimer en la Comunidad Latina

Rudolph Tanzi, PhD, of the Harvard Medical School describes a fundamental problem with modern-day treatment of Alzheimer's disease. Series: "Wellbeing " [Health and Medicine] [Show ID: 34243]

A Flaw in Modern-Day Alzheimer's Treatment

Dale Bredesen, MD, UCSF and UCLA, discusses how environmental toxins may lead to Alzheimers disease. Series: "UCSF Consortium for Obesity Assessment, Study and Treatment" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 34090]

Metabolic Health Alzheimer's Dementogens Exposome: The Hidden Epidemic

There are different types of genetic influences on people's risk of developing Alzheimer's disease. Douglas Galasko, MD, of the UCSD Shiley-Marcos Alzheimer’s Disease Research Center joins William Mobley, MD, PhD to discuss these genes, how they are being studied, and what being a carrier of Alzheimer's associated genes means. Learn more about penetrance and expressivity, genome-wide association studies, and more. Series: "Brain Channel" [Health and Medicine] [Show ID: 33725]

What Role Do Genetics Play in Alzheimer’s? - On Our Mind

How do you model a disease process that stretches out over 20 years in a way that helps you intervene in that process? In the inaugural Shiley Endowed Lecture, Bradley Hyman, MD, PhD shares his research on the progression of Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33992]

Studying the Progression of Alzheimer's Disease with Bradley Hyman MD PhD - Shiley Endowed Lecture

Don't miss these vital updates on the latest in Alzheimer's and dementia care and research from the University of California.

hubhopper

Alzheimer's Disease (Video)

hubhopper